StemCells Inc Stock Nasdaq
Equities
US85857R2040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.11M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 88-08-01 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 21-12-31 |
Chief Tech/Sci/R&D Officer | - | Nov. 30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 16-11-27 |
Director/Board Member | 66 | 17-12-11 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 20-07-31 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |